The Effects of “Dava al-Basal”, a Persian Medicine Product, on Sexual Dysfunction and Testosterone Levels in Men Undergoing Methadone Maintenance Treatment: a Randomized Double-Blind Clinical Trial
نویسندگان
1 Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2 School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
3 School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
4 Traditional Medicine and Materia Medica Research Center and Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5 Department of Traditional Pharmacy, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran
6 School of Aerospace and Subaquatic Medicine, Aja University of Medical Sciences, Tehran, Iran.
7 Traditional Medicine and Materia Medica Research Center and Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
doi
10.22127/rjp.2025.495400.2688چکیده
Background and objectives: Sexual issues, especially erectile dysfunction, are common among men undergoing methadone maintenance treatment (MMT). This study aimed to explore the effects of a Persian Medicine product, “Dava al-basal”, on erectile dysfunction and testosterone levels in men receiving MMT. Methods: This double-blind randomized clinical trial involved 60 men who were randomly assigned to two groups. The intervention group received 20mL of “Dava al-basal” daily, a syrup composed of white onion juice, ginger, and honey, while the placebo group received a simple syrup for eight weeks. Participants were evaluated before the intervention and again at the end of the study using the International Index of Erectile Function Questionnaire (IIEF) and measuring total testosterone levels. Results: The IIEF scores showed no significant changes following the interventions in either group (p-value>0.05). In the intervention group, participants had a testosterone level of 197.67±23.08 ng/dL at the beginning of the study, which increased to 325.23±32.73 ng/dL after the intervention (p-value<0.001). In contrast, the placebo group had a testosterone level of 215.33±28.35 ng/dL before the intervention, which decreased to 194.17±32.46 ng/dL afterward (p-value = 0.047). The results indicated a 64% increase in testosterone levels in the intervention group, compared to a 10% decrease in the placebo group; the difference was statistically significant (p-value<0.001). Conclusion: "Dava al-basal", showed the potential to increase testosterone levels in men undergoing MMT; however, it did not enhance their sexual function. Further research with longer intervention periods and the assessment of additional laboratory indices is recommended to validate the findings of this study.